Thursday November 26 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Leukemia Lymphocytic Chronic

Download PDF containing detailed information.PDF Version

Image Results

Loading...

Recent Publications on Leukemia Lymphocytic Chronic:

Pubmed Logo
5-year survival in patients with relapsed or refractory chronic lymphocytic leukemia in a randomized, phase III trial of fludarabine plus cyclophosphamide with or without oblimersen.
PURPOSE: A randomized trial of oblimersen plus...
18th November, 2009
Division of Hematology, The University of Texas M. D. Anderson Cancer J Clin Oncol. 2009 Nov 1;27(31):5208-12. Epub 2009 Sep 8.
DOI Direct Link
Activation of HLA-G expression by 5-aza-2 - deoxycytidine in malignant hematopoetic cells isolated from leukemia patients.
Human leukocyte antigen - G (HLA-G) is a non-classical HLA class I antigen...
18th November, 2009
Cancer Research Institute, Slovak Academy of Sciences, Bratislava, Slovak Neoplasma. 2009;56(6):514-20.
Karyotype-specific microRNA signature in chronic lymphocytic leukemia.
Chromosomal abnormalities, immunoglobulin heavy chain variable-region...
18th November, 2009
Department of Molecular Virology, Immunology, and Medical Genetics and Blood. 2009 Oct 29;114(18):3872-9. Epub 2009 Aug 28.
DOI Direct Link
Absence of the V617F JAK2 mutation in the lymphoid compartment in a patient with essential thrombocythemia and B-chronic lymphocytic leukemia and in two relatives with lymphoproliferative disorders.
BACKGROUND: Myeloproliferative neoplasms likely involve both myeloid and...
17th November, 2009
Division of Hematology, University of Messina, Policlinico G. Martino, Acta Haematol. 2009;122(1):46-9. Epub 2009 Oct 7.
DOI Direct Link
Detection of chromosomal abnormalities associated with chronic lymphocytic leukemia: what is the best method?
B-cell chronic lymphocytic leukemia (CLL) follows a heterogeneous clinical...
13th November, 2009
Laboratory of Hematology and Cytogenetics, Hospital Avicenne, Bobigny Cancer Genet Cytogenet. 2009 Nov;195(1):37-42.
DOI Direct Link

View more research publications.

Press Releases About Leukemia Lymphocytic Chronic:

BioPortfolio Logo
Reportlinker Adds Wound Care Products - A World Market Analysis 25th November, 2009 Reportlinker
NEW YORK, Nov. 25 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Wound Care Products - A World Market Analysis http://www.reportlinker.com
Reportlinker Adds Therapeutic Apheresis - A US Market Review 25th November, 2009 Reportlinker
NEW YORK, Nov. 25 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Therapeutic Apheresis - A US Market Review http://www.reportlinker.com
Ambit Biosciences Corporation Announces Presentations Profiling AC220 Clinical and Non-Clinical Data at 51st American Society of Hematology Annual Meeting 24th November, 2009 Ambit Biosciences Corporation
SAN DIEGO, Nov. 24 /PRNewswire/ -- Ambit Biosciences Corporation announced today that there will be multiple presentations evaluating AC220, a novel second generation FLT3 inhibitor, in AML at the
Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards 23rd November, 2009 Amgen
THOUSAND OAKS, Calif., Nov. 23 /PRNewswire-FirstCall/ -- Amgen (Nasdaq: AMGN) was honored with two 2009 Scrip Awards, winning for Best Overall Pipeline and for Best New Drug for Nplate® (romiplostim)
DaVita Launches Minority Bank Initiative with $1 Million Investment in Industrial Bank of Washington, D.C. to Support Underserved Communities 23rd November, 2009 DaVita Inc.
Partnerships with Minority Banks in Washington D.C., New York City, Los Angeles and Columbia, S.C. Intended to Spur Economic Growth and Revitalization WASHINGTON, Nov. 23 /PRNewswire-USNewswire/ --

BioNews Results for Leukemia Lymphocytic Chronic:

RSS Logo
BioPortfolio Logo
Genentech And Biogen Idec Receive A Complete Response From The FDA For Rituxan For Chronic Lymphocytic Leukemi
Medical News Today:  Nov 20 2009 4:20AM Matching: leukemia lymphocytic chronic
Nov 18, 2009
Genentech:  Nov 20 2009 7:04AM Matching: leukemia lymphocytic chronic
Medical News: Genentech And Biogen Idec Receive A Complete Response From The FDA For Rituxan For Chronic Lymphocytic Leukemia
BioFind:  Nov 20 2009 7:41AM Matching: leukemia lymphocytic chronic
Genentech and Biogen Idec Receive a Complete Response from the FDA for Rituxan for Chronic Lymphocytic Leukemia
SmartBrief:  Nov 19 2009 6:17AM Matching: leukemia lymphocytic chronic
Genentech and Biogen Idec Receive a Complete Response from the FDA for Rituxan for Chronic Lymphocytic Leukemia
Yahoo! Canada:  Nov 18 2009 11:54PM Matching: leukemia lymphocytic chronic
Promote your company here: BioNewsCast - Press Release Distribution

View more news.

BioPortfolio Ltd. offers e-mail and postal lists for Leukemia Lymphocytic Chronic scientists - we have details of around 776 individuals working on Leukemia Lymphocytic Chronic .


This page has been viewed 333 times
Recent Search Terms used to find this page: lymphocytic leukemia | lymphocytic leukemia | lymphocytic leukemia | leukemia | .
Browse BioPortfolio's InDepth service - alphabetically: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z or by Most Publications, recently searched for, or most viewed.

Search for Leukemia Lymphocytic Chronic across BioPortfolio, or for Leukemia Lymphocytic Chronic Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH. Thumbshots from Thumbshots.org

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.